 | • レポートコード：MRC2Q12-02282 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ケトプロフェンAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ケトプロフェンAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ケトプロフェンAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ケトプロフェンAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのケトプロフェンAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のケトプロフェンAPIの売上および2028年までの予測に焦点を当てています。 ケトプロフェンAPIのグローバル主要企業には、Hubei Xunda Pharmaceutical、Nanjing Dorra Pharmaceutical Technology、Zhejiang Jiuzhou Pharmaceutical、Anhui Sinotech Industrial、Mac-Chem Products (India)、Aalidhra Pharmachem、BEC Chemicals、KOLON Life Science、Midas Pharma、Mutual Pharmaceutical、Osmopharm、Saurav Chemicals、Solara Active Pharma Sciences、Temmler Pharma GmbH & Co.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ケトプロフェンAPI市場は、タイプとアプリケーションによって区分されます。世界のケトプロフェンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.99、0.995、0.999、その他 【アプリケーション別セグメント】 錠剤、カプセル、ゲル、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ケトプロフェンAPI製品概要 - タイプ別市場（0.99、0.995、0.999、その他） - アプリケーション別市場（錠剤、カプセル、ゲル、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のケトプロフェンAPI販売量予測2017-2028 - 世界のケトプロフェンAPI売上予測2017-2028 - ケトプロフェンAPIの地域別販売量 - ケトプロフェンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ケトプロフェンAPI販売量 - 主要メーカー別ケトプロフェンAPI売上 - 主要メーカー別ケトプロフェンAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.99、0.995、0.999、その他） - ケトプロフェンAPIのタイプ別販売量 - ケトプロフェンAPIのタイプ別売上 - ケトプロフェンAPIのタイプ別価格 ・アプリケーション別市場規模（錠剤、カプセル、ゲル、その他） - ケトプロフェンAPIのアプリケーション別販売量 - ケトプロフェンAPIのアプリケーション別売上 - ケトプロフェンAPIのアプリケーション別価格 ・北米市場 - 北米のケトプロフェンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のケトプロフェンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのケトプロフェンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のケトプロフェンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のケトプロフェンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のケトプロフェンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のケトプロフェンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のケトプロフェンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのケトプロフェンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のケトプロフェンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Hubei Xunda Pharmaceutical、Nanjing Dorra Pharmaceutical Technology、Zhejiang Jiuzhou Pharmaceutical、Anhui Sinotech Industrial、Mac-Chem Products (India)、Aalidhra Pharmachem、BEC Chemicals、KOLON Life Science、Midas Pharma、Mutual Pharmaceutical、Osmopharm、Saurav Chemicals、Solara Active Pharma Sciences、Temmler Pharma GmbH & Co. ・産業チェーン及び販売チャネル分析 - ケトプロフェンAPIの産業チェーン分析 - ケトプロフェンAPIの原材料 - ケトプロフェンAPIの生産プロセス - ケトプロフェンAPIの販売及びマーケティング - ケトプロフェンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ケトプロフェンAPIの産業動向 - ケトプロフェンAPIのマーケットドライバー - ケトプロフェンAPIの課題 - ケトプロフェンAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Ketoprofen API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Ketoprofen API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Ketoprofen API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Ketoprofen API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Ketoprofen API include Hubei Xunda Pharmaceutical, Nanjing Dorra Pharmaceutical Technology, Zhejiang Jiuzhou Pharmaceutical, Anhui Sinotech Industrial, Mac-Chem Products (India), Aalidhra Pharmachem, BEC Chemicals, KOLON Life Science and Midas Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Ketoprofen API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Ketoprofen API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Ketoprofen API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Ketoprofen API market. Further, it explains the major drivers and regional dynamics of the global Ketoprofen API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Hubei Xunda Pharmaceutical
Nanjing Dorra Pharmaceutical Technology
Zhejiang Jiuzhou Pharmaceutical
Anhui Sinotech Industrial
Mac-Chem Products (India)
Aalidhra Pharmachem
BEC Chemicals
KOLON Life Science
Midas Pharma
Mutual Pharmaceutical
Osmopharm
Saurav Chemicals
Solara Active Pharma Sciences
Temmler Pharma GmbH & Co.
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Ketoprofen API Segment by Purity
0.99
0.995
0.999
Others
Ketoprofen API Segment by Application
Tablets
Capsules
Gel
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Ketoprofen API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ketoprofen API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Ketoprofen API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Ketoprofen API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Ketoprofen API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ketoprofen API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Ketoprofen API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Ketoprofen API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Hubei Xunda Pharmaceutical, Nanjing Dorra Pharmaceutical Technology, Zhejiang Jiuzhou Pharmaceutical, Anhui Sinotech Industrial, Mac-Chem Products (India), Aalidhra Pharmachem, BEC Chemicals, KOLON Life Science and Midas Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Ketoprofen API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Ketoprofen API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Ketoprofen API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ketoprofen API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Ketoprofen API Product Introduction
1.2 Market by Purity
1.2.1 Global Ketoprofen API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.99
1.2.3 0.995
1.2.4 0.999
1.2.5 Others
1.3 Market by Application
1.3.1 Global Ketoprofen API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Gel
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Ketoprofen API Production
2.1 Global Ketoprofen API Production Capacity (2017-2028)
2.2 Global Ketoprofen API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Ketoprofen API Production by Region
2.3.1 Global Ketoprofen API Historic Production by Region (2017-2022)
2.3.2 Global Ketoprofen API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Ketoprofen API Sales in Volume & Value Estimates and Forecasts
3.1 Global Ketoprofen API Sales Estimates and Forecasts 2017-2028
3.2 Global Ketoprofen API Revenue Estimates and Forecasts 2017-2028
3.3 Global Ketoprofen API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Ketoprofen API Sales by Region
3.4.1 Global Ketoprofen API Sales by Region (2017-2022)
3.4.2 Global Sales Ketoprofen API by Region (2023-2028)
3.5 Global Ketoprofen API Revenue by Region
3.5.1 Global Ketoprofen API Revenue by Region (2017-2022)
3.5.2 Global Ketoprofen API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Ketoprofen API Production Capacity by Manufacturers
4.2 Global Ketoprofen API Sales by Manufacturers
4.2.1 Global Ketoprofen API Sales by Manufacturers (2017-2022)
4.2.2 Global Ketoprofen API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Ketoprofen API in 2021
4.3 Global Ketoprofen API Revenue by Manufacturers
4.3.1 Global Ketoprofen API Revenue by Manufacturers (2017-2022)
4.3.2 Global Ketoprofen API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Ketoprofen API Revenue in 2021
4.4 Global Ketoprofen API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Ketoprofen API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Ketoprofen API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Ketoprofen API Sales by Purity
5.1.1 Global Ketoprofen API Historical Sales by Purity (2017-2022)
5.1.2 Global Ketoprofen API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Ketoprofen API Sales Market Share by Purity (2017-2028)
5.2 Global Ketoprofen API Revenue by Purity
5.2.1 Global Ketoprofen API Historical Revenue by Purity (2017-2022)
5.2.2 Global Ketoprofen API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Ketoprofen API Revenue Market Share by Purity (2017-2028)
5.3 Global Ketoprofen API Price by Purity
5.3.1 Global Ketoprofen API Price by Purity (2017-2022)
5.3.2 Global Ketoprofen API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Ketoprofen API Sales by Application
6.1.1 Global Ketoprofen API Historical Sales by Application (2017-2022)
6.1.2 Global Ketoprofen API Forecasted Sales by Application (2023-2028)
6.1.3 Global Ketoprofen API Sales Market Share by Application (2017-2028)
6.2 Global Ketoprofen API Revenue by Application
6.2.1 Global Ketoprofen API Historical Revenue by Application (2017-2022)
6.2.2 Global Ketoprofen API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Ketoprofen API Revenue Market Share by Application (2017-2028)
6.3 Global Ketoprofen API Price by Application
6.3.1 Global Ketoprofen API Price by Application (2017-2022)
6.3.2 Global Ketoprofen API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Ketoprofen API Market Size by Purity
7.1.1 North America Ketoprofen API Sales by Purity (2017-2028)
7.1.2 North America Ketoprofen API Revenue by Purity (2017-2028)
7.2 North America Ketoprofen API Market Size by Application
7.2.1 North America Ketoprofen API Sales by Application (2017-2028)
7.2.2 North America Ketoprofen API Revenue by Application (2017-2028)
7.3 North America Ketoprofen API Sales by Country
7.3.1 North America Ketoprofen API Sales by Country (2017-2028)
7.3.2 North America Ketoprofen API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Ketoprofen API Market Size by Purity
8.1.1 Europe Ketoprofen API Sales by Purity (2017-2028)
8.1.2 Europe Ketoprofen API Revenue by Purity (2017-2028)
8.2 Europe Ketoprofen API Market Size by Application
8.2.1 Europe Ketoprofen API Sales by Application (2017-2028)
8.2.2 Europe Ketoprofen API Revenue by Application (2017-2028)
8.3 Europe Ketoprofen API Sales by Country
8.3.1 Europe Ketoprofen API Sales by Country (2017-2028)
8.3.2 Europe Ketoprofen API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Ketoprofen API Market Size by Purity
9.1.1 Asia Pacific Ketoprofen API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Ketoprofen API Revenue by Purity (2017-2028)
9.2 Asia Pacific Ketoprofen API Market Size by Application
9.2.1 Asia Pacific Ketoprofen API Sales by Application (2017-2028)
9.2.2 Asia Pacific Ketoprofen API Revenue by Application (2017-2028)
9.3 Asia Pacific Ketoprofen API Sales by Region
9.3.1 Asia Pacific Ketoprofen API Sales by Region (2017-2028)
9.3.2 Asia Pacific Ketoprofen API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Ketoprofen API Market Size by Purity
10.1.1 Latin America Ketoprofen API Sales by Purity (2017-2028)
10.1.2 Latin America Ketoprofen API Revenue by Purity (2017-2028)
10.2 Latin America Ketoprofen API Market Size by Application
10.2.1 Latin America Ketoprofen API Sales by Application (2017-2028)
10.2.2 Latin America Ketoprofen API Revenue by Application (2017-2028)
10.3 Latin America Ketoprofen API Sales by Country
10.3.1 Latin America Ketoprofen API Sales by Country (2017-2028)
10.3.2 Latin America Ketoprofen API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Ketoprofen API Market Size by Purity
11.1.1 Middle East and Africa Ketoprofen API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Ketoprofen API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Ketoprofen API Market Size by Application
11.2.1 Middle East and Africa Ketoprofen API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Ketoprofen API Revenue by Application (2017-2028)
11.3 Middle East and Africa Ketoprofen API Sales by Country
11.3.1 Middle East and Africa Ketoprofen API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Ketoprofen API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Hubei Xunda Pharmaceutical
12.1.1 Hubei Xunda Pharmaceutical Corporation Information
12.1.2 Hubei Xunda Pharmaceutical Overview
12.1.3 Hubei Xunda Pharmaceutical Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Hubei Xunda Pharmaceutical Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Hubei Xunda Pharmaceutical Recent Developments
12.2 Nanjing Dorra Pharmaceutical Technology
12.2.1 Nanjing Dorra Pharmaceutical Technology Corporation Information
12.2.2 Nanjing Dorra Pharmaceutical Technology Overview
12.2.3 Nanjing Dorra Pharmaceutical Technology Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Nanjing Dorra Pharmaceutical Technology Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Nanjing Dorra Pharmaceutical Technology Recent Developments
12.3 Zhejiang Jiuzhou Pharmaceutical
12.3.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
12.3.2 Zhejiang Jiuzhou Pharmaceutical Overview
12.3.3 Zhejiang Jiuzhou Pharmaceutical Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Zhejiang Jiuzhou Pharmaceutical Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
12.4 Anhui Sinotech Industrial
12.4.1 Anhui Sinotech Industrial Corporation Information
12.4.2 Anhui Sinotech Industrial Overview
12.4.3 Anhui Sinotech Industrial Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Anhui Sinotech Industrial Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Anhui Sinotech Industrial Recent Developments
12.5 Mac-Chem Products (India)
12.5.1 Mac-Chem Products (India) Corporation Information
12.5.2 Mac-Chem Products (India) Overview
12.5.3 Mac-Chem Products (India) Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Mac-Chem Products (India) Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mac-Chem Products (India) Recent Developments
12.6 Aalidhra Pharmachem
12.6.1 Aalidhra Pharmachem Corporation Information
12.6.2 Aalidhra Pharmachem Overview
12.6.3 Aalidhra Pharmachem Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Aalidhra Pharmachem Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Aalidhra Pharmachem Recent Developments
12.7 BEC Chemicals
12.7.1 BEC Chemicals Corporation Information
12.7.2 BEC Chemicals Overview
12.7.3 BEC Chemicals Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 BEC Chemicals Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 BEC Chemicals Recent Developments
12.8 KOLON Life Science
12.8.1 KOLON Life Science Corporation Information
12.8.2 KOLON Life Science Overview
12.8.3 KOLON Life Science Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 KOLON Life Science Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 KOLON Life Science Recent Developments
12.9 Midas Pharma
12.9.1 Midas Pharma Corporation Information
12.9.2 Midas Pharma Overview
12.9.3 Midas Pharma Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Midas Pharma Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Midas Pharma Recent Developments
12.10 Mutual Pharmaceutical
12.10.1 Mutual Pharmaceutical Corporation Information
12.10.2 Mutual Pharmaceutical Overview
12.10.3 Mutual Pharmaceutical Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Mutual Pharmaceutical Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Mutual Pharmaceutical Recent Developments
12.11 Osmopharm
12.11.1 Osmopharm Corporation Information
12.11.2 Osmopharm Overview
12.11.3 Osmopharm Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Osmopharm Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Osmopharm Recent Developments
12.12 Saurav Chemicals
12.12.1 Saurav Chemicals Corporation Information
12.12.2 Saurav Chemicals Overview
12.12.3 Saurav Chemicals Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Saurav Chemicals Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Saurav Chemicals Recent Developments
12.13 Solara Active Pharma Sciences
12.13.1 Solara Active Pharma Sciences Corporation Information
12.13.2 Solara Active Pharma Sciences Overview
12.13.3 Solara Active Pharma Sciences Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Solara Active Pharma Sciences Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Solara Active Pharma Sciences Recent Developments
12.14 Temmler Pharma GmbH & Co.
12.14.1 Temmler Pharma GmbH & Co. Corporation Information
12.14.2 Temmler Pharma GmbH & Co. Overview
12.14.3 Temmler Pharma GmbH & Co. Ketoprofen API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Temmler Pharma GmbH & Co. Ketoprofen API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Temmler Pharma GmbH & Co. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ketoprofen API Industry Chain Analysis
13.2 Ketoprofen API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ketoprofen API Production Mode & Process
13.4 Ketoprofen API Sales and Marketing
13.4.1 Ketoprofen API Sales Channels
13.4.2 Ketoprofen API Distributors
13.5 Ketoprofen API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Ketoprofen API Industry Trends
14.2 Ketoprofen API Market Drivers
14.3 Ketoprofen API Market Challenges
14.4 Ketoprofen API Market Restraints
15 Key Finding in The Global Ketoprofen API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
| 【ケトプロフェンAPIについて】 ケトプロフェンは、非ステロイド性抗炎症薬（NSAIDs）に分類される医薬品であり、主に痛みや炎症を軽減するために使用されます。以下では、ケトプロフェンの定義、特徴、種類、用途、さらには関連技術について詳しく説明いたします。 まず、ケトプロフェンの定義ですが、これは化学式C16H14O3で表される化合物で、プロピオン酸系のNSAIDsとして知られています。1980年代に市場に登場し、以降多くの国で様々な配合剤として使用されています。ケトプロフェンは、主に痛みの緩和、炎症の抑制、そして解熱剤としての作用を持つため、医療現場で広く用いられています。 ケトプロフェンの重要な特徴の一つは、その抗炎症作用です。具体的には、体内のプロスタグランジン合成を阻害することにより、炎症反応を軽減します。プロスタグランジンは、体内での炎症や痛みの感覚を引き起こす重要な物質であるため、その合成を抑えることで、効果的に痛みを和らげることができます。また、ケトプロフェンには鎮痛作用だけでなく、解熱作用もあり、これらの特性から、さまざまな疾患の管理に使用されています。 次に、ケトプロフェンの種類ですが、通常、ケトプロフェンは経口剤、外用剤、注射剤といった形態で提供されます。経口剤は錠剤やカプセルとして入手可能であり、主に日常的な痛みや慢性的な疾患の治療に用いられます。外用剤は、クリームやゲル状の製品として皮膚に塗布され、局所的な痛みや炎症に対して効果を発揮します。また、注射剤は迅速な効果が求められる場合に使用されることがあります。 ケトプロフェンの用途は多岐にわたります。主に、筋肉痛、関節リウマチ、変形性関節症、外傷後の痛み、手術後の痛みなど、さまざまな痛みに対して適応されます。また、婦人科領域においては、生理痛の緩和にも利用されることがあります。特に、炎症が関連する痛みや、急性の痛みの治療に非常に有用です。 ただし、ケトプロフェンには副作用が存在するため、使用時には注意が必要です。一般的な副作用として、消化器系の不調（吐き気、嘔吐、腹痛など）、頭痛、めまい、皮膚反応などが挙げられます。重篤な場合には、腎機能障害や肝機能障害、アナフィラキシー反応が生じることもあるため、特に既往歴がある患者に対しては慎重に使用されるべきです。 さらに、ケトプロフェンを含むNSAIDsは、心血管系のリスクを高める可能性があることからも注意が必要です。高血圧や心疾患の既往がある方には、他の治療法が検討されることがあります。このようなリスクに対する知識は、患者と医療従事者の間でのコミュニケーションにおいて重要です。 ケトプロフェンの関連技術に関しては、その製剤技術が関係しています。ケトプロフェンは水溶性が低く、生物学的利用能を向上させるための様々な製剤方法が研究されています。たとえば、ナノ技術を用いたドラッグデリバリーシステムや、バイオマテリアルを利用した持続放出製剤の開発が進められています。これにより、ケトプロフェンの効果を最大限に引き出し、副作用を最小限に抑えることが期待されています。 また、ケトプロフェンの処方においては、患者個々の状態に応じた適正な用量や使用期間の設定が求められます。これもまた、医療従事者が持つべき重要な知識の一部です。患者の病歴、現在の健康状態、他の服用薬との相互作用を考慮しながら、最適な治療を選択することが求められます。 加えて、ケトプロフェンは、その性質上、長期的な使用には注意が必要です。NSAIDs全般に言えることですが、長期使用は消化器系出血や腎障害のリスクを高めるため、定期的なモニタリングが推奨される場合があります。これに対処するためのガイドラインも策定されており、医療機関での安全な使用が強調されています。 最後に、ケトプロフェンの薬物動態について言及します。この薬剤は、経口投与後に消化管から速やかに吸収され、血中濃度が比較的早くピークに達します。また、肝臓で代謝されて最終的に排泄される際には、メタボリック成分が生じることがあります。このため、肝機能が低下している場合、薬物の効果や副作用に影響を及ぼす可能性があるため、使用に際しては医療機関での適切な診断と指導が求められます。 ケトプロフェンは、幅広い用途を持ち、痛みや炎症の治療に不可欠な医薬品ですが、その使用に当たっては副作用やリスクを十分に理解し、適切な管理が必要です。医療従事者と患者の間でのコミュニケーションの重要性も再認識され、より安全かつ効果的な治療が行えるよう努めていくことが求められます。 |